{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:01:41Z","timestamp":1788919301501,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1038\/ncpendmet0592","type":"journal-article","created":{"date-parts":[[2007,8,20]],"date-time":"2007-08-20T15:49:33Z","timestamp":1187624973000},"page":"662-666","source":"Crossref","is-referenced-by-count":27,"title":["Treatment of amiodarone-associated thyrotoxicosis"],"prefix":"10.1038","volume":"3","author":[{"given":"Jayne A","family":"Franklyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D","family":"Gammage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpendmet0592_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1136\/hrt.79.2.121","volume":"79","author":"CM Newman","year":"1998","unstructured":"Newman CM  et al. (1998) Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy. Heart 79: 121\u2013127","journal-title":"Heart"},{"key":"BFncpendmet0592_CR2","first-page":"240","volume":"22","author":"E Martino","year":"2001","unstructured":"Martino E  et al. (2001) The effects of amiodarone on the thyroid. Endocr Rev 22: 240\u2013254","journal-title":"Endocr Rev"},{"key":"BFncpendmet0592_CR3","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1136\/bmj.305.6847.224","volume":"305","author":"PH Davies","year":"1992","unstructured":"Davies PH  et al. (1992) Treatment of amiodarone induced thyrotoxicosis with carbimazole alone and continuation of amiodarone. BMJ 305: 224\u2013225","journal-title":"BMJ"},{"key":"BFncpendmet0592_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/00000478-198703000-00004","volume":"11","author":"TC Smyrk","year":"1987","unstructured":"Smyrk TC  et al. (1987) Pathology of the thyroid in amiodarone-associated thyrotoxicosis. Am J Surg Pathol 11: 197\u2013204","journal-title":"Am J Surg Pathol"},{"key":"BFncpendmet0592_CR5","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1161\/circ.105.11.1275","volume":"105","author":"F Osman","year":"2002","unstructured":"Osman F  et al. (2002) Successful treatment of amiodarone-induced thyrotoxicosis. Circulation 105: 1275\u20131277","journal-title":"Circulation"},{"key":"BFncpendmet0592_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1046\/j.0300-0664.2001.01457.x","volume":"56","author":"SE Eaton","year":"2002","unstructured":"Eaton SE  et al. (2002) Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography. Clin Endocrinol (Oxf) 56: 33\u201338","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFncpendmet0592_CR7","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.amjmed.2004.11.028","volume":"118","author":"S Basaria","year":"2005","unstructured":"Basaria S and Cooper DS (2005) Amiodarone and the thyroid. Am J Med 118: 706\u2013714","journal-title":"Am J Med"},{"key":"BFncpendmet0592_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1210\/jcem.86.1.7119","volume":"86","author":"GH Daniels","year":"2001","unstructured":"Daniels GH (2001) Amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 86: 3\u20138","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0592_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1530\/acta.0.1190167","volume":"119","author":"E Martino","year":"1988","unstructured":"Martino E  et al. (1988) Radioactive iodine thyroid uptake in patients with amiodarone-iodine-induced thyroid dysfunction. Acta Endocrinol (Copenh) 119: 167\u2013173","journal-title":"Acta Endocrinol (Copenh)"},{"key":"BFncpendmet0592_CR10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1089\/thy.1997.7.541","volume":"7","author":"F Bogazzi","year":"1997","unstructured":"Bogazzi F  et al. (1997) Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Thyroid 7: 541\u2013545","journal-title":"Thyroid"},{"key":"BFncpendmet0592_CR11","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/j.1365-2265.2004.02119.x","volume":"61","author":"L Bartalena","year":"2004","unstructured":"Bartalena L  et al. (2004) Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association. Clin Endocrinol (Oxf) 61: 494\u2013502","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFncpendmet0592_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jacc.2006.08.042","volume":"49","author":"F Osman","year":"2007","unstructured":"Osman F  et al. (2007) Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case\u2013control study. J Am Coll Cardiol 49: 71\u201381","journal-title":"J Am Coll Cardiol"},{"key":"BFncpendmet0592_CR13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.amjmed.2003.09.036","volume":"116","author":"JS Hermida","year":"2004","unstructured":"Hermida JS  et al. (2004) Radioiodine ablation of the thyroid to allow the reintroduction of amiodarone treatment in patients with a prior history of amiodarone-induced thyrotoxicosis. Am J Med 116: 345\u2013348","journal-title":"Am J Med"},{"key":"BFncpendmet0592_CR14","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1210\/jc.2006-2059","volume":"92","author":"F Bogazzi","year":"2007","unstructured":"Bogazzi F  et al. (2007) Glucocorticoid response to amiodarone-induced thyrotoxicosis due to destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations. J Clin Endocrinol Metab 92: 556\u2013562","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0592_CR15","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1210\/jc.2002-021874","volume":"88","author":"F Bogazzi","year":"2003","unstructured":"Bogazzi F  et al. (2003) Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study. J Clin Endocrinol Metab 88: 1999\u20132002","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Nature Clinical Practice Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0592.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0592","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0592.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:53:51Z","timestamp":1684439631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpendmet0592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["BFncpendmet0592"],"URL":"https:\/\/doi.org\/10.1038\/ncpendmet0592","relation":{},"ISSN":["1745-8366","1745-8374"],"issn-type":[{"value":"1745-8366","type":"print"},{"value":"1745-8374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}